Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karin D Rodland

Showing results (1-10 of 115) with videos related to

Pageof 12
Sort By:
Clinical Chemistry|December 6, 2013
As if biomarker discovery isn't hard enough: the consequences of poorly characterized reagentsKarin D Rodland
Disease Markers|October 27, 2004
Mass spectrometry and biomarker developmentKarin D Rodland
Clinical Biochemistry|July 6, 2004
Proteomics and cancer diagnosis: the potential of mass spectrometryKarin D Rodland
Disease Markers|June 11, 2010
Systems biology and biomarker discoveryKarin D Rodland
Cell Calcium|June 18, 2004
The role of the calcium-sensing receptor in cancerKarin D Rodland
Expert Review of Proteomics|October 29, 2025
Toward real clinical utility: leveraging comprehensive cancer proteomic datasets for clinical insightKarin D Rodland, Bing Zhang
Cancer Metastasis Reviews|March 5, 2015
Proteomics of ovarian cancer: functional insights and clinical applicationsMohamed A Elzek, Karin D Rodland
Cancer Biomarkers : Section a of Disease Markers|November 3, 2011
Searching for a system: the quest for ovarian cancer biomarkersKarin D Rodland, Nita J Maihle
Vitamins and Hormones|March 17, 2018
Characterization of the Ovarian Tumor PeptidomeTao Liu, Karin D Rodland, Richard D Smith
Cancer Journal (Sudbury, Mass.)|May 26, 2018
Moonshot Objectives: Catalyze New Scientific Breakthroughs-ProteogenomicsKarin D Rodland, Paul Piehowski, Richard D Smith
Pageof 12

Showing results (1-10 of 115) with videos related to

Sort By:
Pageof 12
Clinical Chemistry|December 6, 2013
As if biomarker discovery isn't hard enough: the consequences of poorly characterized reagentsKarin D Rodland
Disease Markers|October 27, 2004
Mass spectrometry and biomarker developmentKarin D Rodland
Clinical Biochemistry|July 6, 2004
Proteomics and cancer diagnosis: the potential of mass spectrometryKarin D Rodland
Disease Markers|June 11, 2010
Systems biology and biomarker discoveryKarin D Rodland
Cell Calcium|June 18, 2004
The role of the calcium-sensing receptor in cancerKarin D Rodland
Expert Review of Proteomics|October 29, 2025
Toward real clinical utility: leveraging comprehensive cancer proteomic datasets for clinical insightKarin D Rodland, Bing Zhang
Cancer Metastasis Reviews|March 5, 2015
Proteomics of ovarian cancer: functional insights and clinical applicationsMohamed A Elzek, Karin D Rodland
Cancer Biomarkers : Section a of Disease Markers|November 3, 2011
Searching for a system: the quest for ovarian cancer biomarkersKarin D Rodland, Nita J Maihle
Vitamins and Hormones|March 17, 2018
Characterization of the Ovarian Tumor PeptidomeTao Liu, Karin D Rodland, Richard D Smith
Cancer Journal (Sudbury, Mass.)|May 26, 2018
Moonshot Objectives: Catalyze New Scientific Breakthroughs-ProteogenomicsKarin D Rodland, Paul Piehowski, Richard D Smith
Pageof 12